Journal article
Efficacy of Agomelatine 25–50 mg for the Treatment of Anxious Symptoms and Functional Impairment in Generalized Anxiety Disorder: A Meta-Analysis of Three Placebo-Controlled Studies
Abstract
IntroductionThe purpose of this study is to investigate the effects of agomelatine on anxious symptoms and functional impairment in a pooled dataset from randomized placebo-controlled trials for generalized anxiety disorder (GAD).MethodsData from three randomized, placebo-controlled trials that evaluated the efficacy of agomelatine 25–50 mg were pooled. The short-term (12 weeks) efficacy of agomelatine was assessed in regards to (1) anxious …
Authors
Stein DJ; Khoo J-P; Picarel-Blanchot F; Olivier V; Van Ameringen M
Journal
Advances in Therapy, Vol. 38, No. 3, pp. 1567–1583
Publisher
Springer Nature
Publication Date
March 2021
DOI
10.1007/s12325-020-01583-9
ISSN
0741-238X